MedTrace Logo

Prospective Ultrafast MRI Radiomics for Breast Cancer

NCT06104189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2023-10-27

No results posted yet for this study

Summary

The goal of this prospective study is to investigate the performance of ultrafast MRI radiomics in classifying histological factors and subtypes of breast cancer compared with standard MRI among radiologists with varying experience. The written informed consent was obtained from all participant. We extracted 1618 radiomic features from ultrafast and standard contrast-enhanced MRI before treatment. Classification of hormonal receptors, human epidermal growth factor receptor 2, and Ki67 status and subtypes was evaluated using the area under the receiver-operating characteristic curve (AUC) with the DeLong test.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI

MRI based classification of breast cancer histological factors and subtypes

Sponsors & Collaborators

  • Korea University Ansan Hospital

    lead OTHER

Principal Investigators

  • Bo Kyoung Seo, MD, PhD · Korea University Ansan Hospital

Eligibility

Min Age
27 Years
Max Age
86 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-11-30
Completion
2023-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06104189 on ClinicalTrials.gov